References
- Parkinson's Disease Information Page [Internet]. Maryland: National Institute of Neurological Disorders and Stroke [cited 2021. February 15]. Available from: https://www.ninds.nih.gov/Disorders/All-Disorders/Parkinsons-disease-Information-Page.
- Kalia LV, Lang AE. Parkinson's disease. Lancet. 2015;386(9996):896–912.
- GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):459–480.
- Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry. 2008;79(4):368–376.
- Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267.
- Tuck MW, Crick RP. The age distribution of primary open angle glaucoma. Ophthalmic Epidemiol. 1998;5(4):173–183.
- Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA. 2014;311(18):1901–1911.
- Quigley HA, Nickells RW, Kerrigan LA, et al. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995;36(5):774–786.
- Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol. 2000;1(2):120–129.
- Pease ME, McKinnon SJ, Quigley HA, et al. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest Ophthalmol Vis Sci. 2000;41(3):764–774.
- Nagatsu T. Parkinson's disease: changes in apoptosis-related factors suggesting possible gene therapy. J Neural Transm (Vienna). 2002;109(5-6):731–745.
- Yenice O, Onal S, Midi I, et al. Visual field analysis in patients with Parkinson's disease. Parkinsonism Relat Disord. 2008;14(3):193–198.
- Pfeiffer RF. Non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord. 2016;22(Suppl 1):S119–S22.
- Bonnet AM, Jutras MF, Czernecki V, et al. Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects. Parkinsons Dis. 2012;2012:198316.
- Lai SW, Lin CL, Liao KF. Glaucoma correlates with increased risk of Parkinson's disease in the elderly: a national-based cohort study in Taiwan. Curr Med Res Opin. 2017;33(8):1511–1516.
- Lin IC, Wang YH, Wang TJ, et al. Glaucoma, Alzheimer's disease, and Parkinson's disease: an 8-year population-based follow-up study. PLOS One. 2014;9(9):e108938.
- Moon JY, Kim HJ, Park YH, et al. Association between open-angle glaucoma and the risks of Alzheimer's and Parkinson's diseases in South Korea: a 10-year nationwide cohort study. Sci Rep. 2018;8(1):11161.
- Methodological Resources. Ottawa (ON): Evidence Partners; [cited 2021. February 20]. Available from: https://www.evidencepartners.com/resources/methodological-resources/.
- Bayer AU, Keller ON, Ferrari F, et al. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol. 2002;133(1):135–137.
- Umunakwe O, Gupta D, Tseng H. Association of open-angle glaucoma with non-Alzheimer's dementia and cognitive impairment. Ophthalmol Glaucoma. 2020;3(6):460–465.
- Yu JG, Feng YF, Xiang Y, et al. Retinal nerve fiber layer thickness changes in Parkinson disease: a meta-analysis. PLOS One. 2014;9(1):e85718.
- Altintaş O, Işeri P, Ozkan B, et al. Correlation between retinal morphological and functional findings and clinical severity in Parkinson's disease. Doc Ophthalmol. 2008;116(2):137–146.